PWM
DNTH icon

Palumbo Wealth Management’s Dianthus Therapeutics DNTH Stock Holding History

Palumbo Wealth Management’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$869K Sell
10,360
-4,607
-31% -$267K 0.21% 80
2025
Q4 		$617K Buy
14,967
+8,317
+125% +$322K 0.15% 109
2025
Q3 		$262K Buy
+6,650
New +$170K 0.08% 151

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Palumbo Wealth Management's DNTH Position: Q1 2026 in Review

Palumbo Wealth Management reduced its Dianthus Therapeutics (DNTH) stake by 31% in Q1 2026, selling an estimated $267K and leaving 10,360 shares worth $869K. The position accounts for 0.21% of the portfolio, ranked #80.

Palumbo Wealth Management first reported a position in DNTH in Q3 2025 and has held it in 3 quarters since. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

  • Palumbo Wealth Management held 10,360 shares of Dianthus Therapeutics worth $869K as of Q1 2026.
  • Palumbo Wealth Management sold 4,607 Dianthus Therapeutics shares in Q1 2026, an estimated $267K.
  • Dianthus Therapeutics made up 0.21% of Palumbo Wealth Management's portfolio in Q1 2026, its #80 holding.
  • Palumbo Wealth Management first reported a position in Dianthus Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on Palumbo Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.